TY - JOUR
T1 - Clinical outcome of dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections
T2 - A single-center retrospective study of 75 cases in India
AU - Kaur, Amarjeet
AU - Gandra, Sumanth
AU - Gupta, Priyanka
AU - Mehta, Yatin
AU - Laxminarayan, Ramanan
AU - Sengupta, Sharmila
N1 - Funding Information:
Funding/support: S.G. and R.L. are supported by ResistanceMap project, which is funded by the Bill & Melinda Gates Foundation (grant no. OPP1112355 ), and the Global Antibiotic Resistance Partnership funded by the Bill & Melinda Gates Foundation.
Publisher Copyright:
© 2017 Association for Professionals in Infection Control and Epidemiology, Inc.
PY - 2017/11/1
Y1 - 2017/11/1
N2 - In this study, we retrospectively evaluated clinical outcomes of 75 patients with dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections over a 5-year period in a single tertiary care hospital in India. We observed a high in-hospital mortality rate of 69.3%. Our findings indicate the urgent need for new antibiotics to treat these infections.
AB - In this study, we retrospectively evaluated clinical outcomes of 75 patients with dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections over a 5-year period in a single tertiary care hospital in India. We observed a high in-hospital mortality rate of 69.3%. Our findings indicate the urgent need for new antibiotics to treat these infections.
KW - Carbapenem resistance
KW - Colistin resistance
KW - India
KW - Klebsiella
UR - http://www.scopus.com/inward/record.url?scp=85028349792&partnerID=8YFLogxK
U2 - 10.1016/j.ajic.2017.06.028
DO - 10.1016/j.ajic.2017.06.028
M3 - Article
C2 - 28807425
AN - SCOPUS:85028349792
SN - 0196-6553
VL - 45
SP - 1289
EP - 1291
JO - American Journal of Infection Control
JF - American Journal of Infection Control
IS - 11
ER -